Overview

A Pharmacodynamic Study With Ticagrelor in African American Patients

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacodynamic effect of ticagrelor in African American patients with stable coronary artery disease.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Clopidogrel
Ticagrelor
Ticlopidine